No Data
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Tiziana Multiple Sclerosis Asset Foralumab Fast Track Application Accepted
Express News | Tiziana Life Sciences Receives FDA Acceptance For Fast Track Designation Submission Of Intranasal Foralumab For Treating Non-Active Secondary-Progressive Multiple Sclerosis (Na-SPMS)
Express News | FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
Tiziana Life Sciences Seeks FDA Fast Track Designation for Foralumab in MS Treatment | NASDAQ:TLSA
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAnitra (AMEX:AZTR) stock rose 17.0% to $0.17 during Friday's after-market session. The company's market cap stands at $5.0 million. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 12